Roman, A.J.; Powers, C.A.; Semenov, E.P.; Sheplock, R.; Aksianiuk, V.; Russell, R.C.; Sumaroka, A.; Garafalo, A.V.; Cideciyan, A.V.; Jacobson, S.G.
Short-Wavelength Sensitive Cone (S-cone) Testing as an Outcome Measure for NR2E3 Clinical Treatment Trials. Int. J. Mol. Sci. 2019, 20, 2497.
https://doi.org/10.3390/ijms20102497
AMA Style
Roman AJ, Powers CA, Semenov EP, Sheplock R, Aksianiuk V, Russell RC, Sumaroka A, Garafalo AV, Cideciyan AV, Jacobson SG.
Short-Wavelength Sensitive Cone (S-cone) Testing as an Outcome Measure for NR2E3 Clinical Treatment Trials. International Journal of Molecular Sciences. 2019; 20(10):2497.
https://doi.org/10.3390/ijms20102497
Chicago/Turabian Style
Roman, Alejandro J., Christian A. Powers, Evelyn P. Semenov, Rebecca Sheplock, Valeryia Aksianiuk, Robert C. Russell, Alexander Sumaroka, Alexandra V. Garafalo, Artur V. Cideciyan, and Samuel G. Jacobson.
2019. "Short-Wavelength Sensitive Cone (S-cone) Testing as an Outcome Measure for NR2E3 Clinical Treatment Trials" International Journal of Molecular Sciences 20, no. 10: 2497.
https://doi.org/10.3390/ijms20102497
APA Style
Roman, A. J., Powers, C. A., Semenov, E. P., Sheplock, R., Aksianiuk, V., Russell, R. C., Sumaroka, A., Garafalo, A. V., Cideciyan, A. V., & Jacobson, S. G.
(2019). Short-Wavelength Sensitive Cone (S-cone) Testing as an Outcome Measure for NR2E3 Clinical Treatment Trials. International Journal of Molecular Sciences, 20(10), 2497.
https://doi.org/10.3390/ijms20102497